Our team has guided multifaceted, industry-first kidney disease research projects worldwide. Browse our case studies below to get a look at what Frenova has helped clients achieve, and continue to visit for new content.
Vifor Case Study: A Pivotol Phase III Study for FDA Approval of Velphoro® (Sucroferric Oxyhydroxide), a Hyperphosphatemia Medication
Hyperphosphatemia, an abnormal elevation of phosphorus levels in the blood, is a common and serious condition in chronic kidney disease (CKD) patients undergoing dialysis treatment. Despite dietary restriction, dialysis treatment and the availability of a number of different phosphate binders to treat this condition, up to 50 percent of patients (depending on the country) are still unable to achieve and maintain their serum phosphorus targets.1 Furthermore, dialysis patients take a total of 19 pills per day,2 of which phosphate binders comprise half of this pill burden …